Arecent market research report entitled Global Plaque Psoriasis Market Size, Share, Growth, Industry Trends and Forecast to 2027 by Data Bridge Market Research team provides comprehensive analysis and in-depth study on the current state of Plaque Psoriasis Industry. This report is provided with complete 350 pages,220 list of tables, 60 no of figures and also infographics.
Share: email Subscribe
Weekly Top Stories Tue, 16 Mar 2021
We have 26 articles this week. #IDEX Corporation Completes Acquisition of #AbelPumps,L.P. #PerkinElmer Completes Acquisition of #OxfordImmunotec Global PLC. #Takeda to Acquire #MaverickTherapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio. #Akerna to Acquire #ViridianSciences. #MonteRosaTherapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform. #CalciMedica Announces $21 Million Series D Financing. #DelonixBioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines. Israeli AI clinical insight company #MedialEarlySign partners with #DatosHealth. #Proscia and #IbexMedical Analytics Partner to Improve Prostate Cancer Diagnosis with AI-powered Workflows. #PhaseBio Pharmaceuticals and #BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab.
Editor's Choice
1. 
Plaque Psoriasis Treatment Market 2027 Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional
2. 
Anticonvulsants Market Research Report by Drug types, by Application – Global Forecast to 2025
3. 
Antipsychotic Drugs Market Research Report by Class, by Application – Global Forecast to 2025
4. 
Antiviral Drugs Market
5. 
Active Pharmaceutical Ingredient Market to Hit USD 261.28 Billion and Exhibit 6.1% CAGR by 2026
Top 10 M&A Transactions
6. 
IDEX Corporation Completes Acquisition of Abel Pumps, L.P.
7. 
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
8. 
Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio
9. 
Grifols Reinforces Its Innovation Strategy After Completing the Acquisition of Gigagen to Boost a Novel Method to Generate a Wide Range of Immunoglobulins
10. 
Akerna to Acquire Viridian Sciences
11. 
ITOCO INC to Acquire Biotech Protocols and Technology Related to Carbon Credit Generation From ECAPFIN S.A.P.I. DE C.V
12. 
IDT Acquires Swift Biosciences, a Pioneer in the Development of Next-Generation Sequencing (NGS) Library Preparation Genomics Kits for Academic, Translational, and Clinical Research
13. 
Brainlab Acquires Mint Medical to Advance Quality and Structure of Data Gathered in Clinical Routine and Research
14. 
ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business
15. 
CenExel Clinical Research Acquires CITrials
Top 3 Venture Funding
16. 
Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-Generation Protein Degradation Platform
17. 
Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of Its Innovative Synthetic Vaccines
18. 
CalciMedica Announces $21 Million Series D Financing
Top 4 Partnerships Announcements
19. 
PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of Bentracimab
20. 
Proscia and Ibex Medical Analytics Partner to Improve Prostate Cancer Diagnosis with AI-Powered Workflows
21. 
Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us